Blog

WBJ: Gaithersburg Rare Disease Startup Vtesse Inc. Nabs $17M in Additional Series A Funding

Gaithersburg biotech startup Vtesse Inc. — a company with a goal to commercialize National Institutes of Health rare disease drug candidates — secured $17 million in additional Series A funding.

Read more via the Washington Business Journal